Patient Reported Outcome Measures in BRCA 1 or 2 mutation carriers
Recruiting
- Conditions
- BRCA 1 or 2 gene mutation, bilateral prophylactic mastectomy, direct breast reconstruction, surveillance, health related quality of lifebilaterale profylactische mastectomie, directe borst reconstructie, BRCA 1 of 2 genmutatie, gezondheid gerelateerde kwaliteit van leven
- Registration Number
- NL-OMON27474
- Lead Sponsor
- Prof. dr. J.M. HendriksHead of Dept. of SurgeryErasmus University Medical CenterRg 226P.O. 20403000 CA Rotterdam(T) 010-7031206
- Brief Summary
ot yet, study is ongoing
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1)> 18 years
2)agreement with participation
Exclusion Criteria
1)no adequate understanding of Dutch language
2)time since surgery <1 year,
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient reported outcome values considering different strategies in breast cancer prevention in woman with BRCA 1 or 2 mutations. Patients will be grouped according to the strategy performed, i.e. bilateral prophylactic mastectomy or breast surveillance. Values will be collected through the HADS and the BREAST-Q.
- Secondary Outcome Measures
Name Time Method ot applicable